SCHEMBL8001464

SCHEMBL8001464

O=C1Nc2ccc([N+](=O)[O-])cc2C1=C(Nc1ccc(-c2nnn[nH]2)cc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CASP3 P42574 2/20 0.40
CAPN9 O14815 1/20 0.40
TGM2 P21980 1/20 0.39
HPGD P15428 2/20 0.39
LMNA P02545 1/20 0.39
PDE4D Q08499 1/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
GSK3B P49841 4/20 0.38
POLB P06746 2/20 0.37
NPC1 O15118 1/20 0.37
MITF O75030 1/20 0.37
RAB9A P51151 1/20 0.37
CHRM1 P11229 1/20 0.37
ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8001461 1.00 EGFR (0.44) EGFRMEN1KMT2ACASP3CAPN9
SCHEMBL6319442 0.87 EGFR (0.54) EGFRMEN1KMT2ACASP3CAPN9
SCHEMBL6319460 0.87 EGFR (0.54) EGFRMEN1KMT2ACASP3CAPN9
SCHEMBL8009869 0.86 KDR (0.37) MEN1KMT2AGSK3BPOLBNPC1
SCHEMBL8009865 0.86 KDR (0.37) MEN1KMT2AGSK3BPOLBNPC1
SCHEMBL28414296 0.86 EGFR (0.55) EGFRMEN1KMT2ACASP3CAPN9
SCHEMBL29642973 0.86 EGFR (0.55) EGFRMEN1KMT2ACASP3CAPN9
SCHEMBL8009947 0.85 EGFR (0.43) EGFRMEN1KMT2ACASP3CAPN9
SCHEMBL8009948 0.85 EGFR (0.43) EGFRMEN1KMT2ACASP3CAPN9
SCHEMBL6320292 0.84 EGFR (0.51) EGFRMEN1KMT2ACASP3CAPN9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6043254-A ANTIPROLIFERATIVE AGENT; ENZYME INHIBITOR BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-03-28 US disclosed
WO-1999051590-A1 SUBSTITUTED INDOLINONES AS KINASE INHIBITORS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-10-14 WO disclosed